Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility
暂无分享,去创建一个
H. Fujii | S. Takenoshita | A. Shabbir | S. Nakajima | Vivien Koh | J. So | W. Yong | K. Mimura | L. Kua | Kensuke Shiraishi | Lim Kee Siang | K. Kono
[1] A. López-Soto,et al. NKG2D signaling in cancer immunosurveillance , 2015, International journal of cancer.
[2] M. Kasahara,et al. Immunohistochemical Validation and Expression Profiling of NKG2D Ligands in a Wide Spectrum of Human Epithelial Neoplasms , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[3] D. Campana,et al. Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer , 2014, International journal of cancer.
[4] A. López-Soto,et al. Molecular Bases for the Regulation of NKG2D Ligands in Cancer , 2014, Front. Immunol..
[5] A. Santoni,et al. The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells , 2014, Front. Immunol..
[6] B. Seliger,et al. The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer , 2013, The Journal of Immunology.
[7] O. Janssen,et al. Shedding of endogenous MHC class I‐related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17 , 2013, International journal of cancer.
[8] T. Spies,et al. Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in Cancer , 2013, The Journal of Immunology.
[9] O. Janssen,et al. Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications , 2013, Scandinavian journal of immunology.
[10] L. Rodrigo,et al. Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition , 2013, Oncoimmunology.
[11] F. Vizoso,et al. Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis , 2013, Oncoimmunology.
[12] Jack Gauldie,et al. Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer , 2013, The Journal of Immunology.
[13] A. G. de Herreros,et al. Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor , 2013, The Journal of Immunology.
[14] Michael Hagemann-Jensen,et al. Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment. , 2013, Molecular immunology.
[15] N. Stanietsky,et al. MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. , 2012, Cancer research.
[16] Eric Vivier,et al. Targeting natural killer cells and natural killer T cells in cancer , 2012, Nature Reviews Immunology.
[17] Jae Kwon Lee,et al. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell. , 2012, Cellular immunology.
[18] B. Seliger,et al. HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines , 2012, The Journal of Immunology.
[19] Dahui Sun,et al. MMP9 mediates MICA shedding in human osteosarcomas , 2011, Cell biology international.
[20] R. Solana,et al. NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions , 2011, Journal of Innate Immunity.
[21] F. Locatelli,et al. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. , 2011, Blood.
[22] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[23] Per Albertsson,et al. Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation , 2010, Cancer Microenvironment.
[24] L. Lanier,et al. Effect of NKG2D ligand expression on host immune responses , 2010, Immunological reviews.
[25] Gang Liu,et al. Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases , 2010, The Journal of Immunology.
[26] G. Ball,et al. NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting , 2009, Clinical Cancer Research.
[27] N. Hayashi,et al. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. , 2009, Cancer research.
[28] Insiya Jafferji,et al. Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells. , 2009, Current immunology reviews.
[29] A. Cerwenka,et al. NKG2D ligands in tumor immunity , 2008, Oncogene.
[30] H. Rammensee,et al. Tumor-associated MICA is shed by ADAM proteases. , 2008, Cancer research.
[31] M. Mason,et al. Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression1 , 2008, The Journal of Immunology.
[32] N. Greenberg,et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. , 2008, Immunity.
[33] L. Frati,et al. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. , 2007, Blood.
[34] A. Vaheri,et al. Cell‐cell contact activation of fibroblasts increases the expression of matrix metalloproteinases , 2006, Annals of medicine.
[35] L. Matrisian,et al. Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.
[36] T. Spies,et al. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB , 1999 .
[37] S. Bauer,et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.